Systemic inflammation biomarkers can identify high tumor mutation burden in lung adenocarcinoma. Fang J, Li Q, Xu N, Yang X, et al. BMC Cancer 2025;25:1543.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fang J, Li Q, Xu N, Yang X, et al. Systemic inflammation biomarkers can identify high tumor mutation burden in lung adenocarcinoma. BMC Cancer 2025;25:1543.
PMID: 41068630